Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Identification of druggable regulators of cell secretion via a kinome-wide screen and high-throughput immunomagnetic cell sorting.

Nature biomedical engineering | 2024

The identification of genetic regulators of cell secretions is challenging because it requires the sorting of a large number of cells according to their secretion patterns. Here we report the development and applicability of a high-throughput microfluidic method for the analysis of the secretion levels of large populations of immune cells. The method is linked with a kinome-wide loss-of-function CRISPR screen, immunomagnetically sorting the cells according to their secretion levels, and the sequencing of their genomes to identify key genetic modifiers of cell secretion. We used the method, which we validated against flow cytometry for cytokines secreted from primary mouse CD4+ (cluster of differentiation 4-positive) T cells, to discover a subgroup of highly co-expressed kinase-coding genes that regulate interferon-gamma secretion by these cells. We validated the function of the kinases identified using RNA interference, CRISPR knockouts and kinase inhibitors and confirmed the druggability of selected kinases via the administration of a kinase inhibitor in an animal model of colitis. The technique may facilitate the discovery of regulatory mechanisms for immune-cell activation and of therapeutic targets for autoimmune diseases.

Pubmed ID: 38012306 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Olfm4 (D6Y5A) XP® Rabbit mAb (Mouse Specific) #39141 (antibody)

RRID:AB_2650511

This monoclonal targets endogenous levels of total mouse Olfm4 protein

View all literature mentions

LRRK2 Antibody (antibody)

RRID:AB_1849213

This unknown targets LRRK2

View all literature mentions

Biotin Antibody, FITC (antibody)

RRID:AB_2733612

This monoclonal targets Biotin

View all literature mentions

Biotin Antibody, APC (antibody)

RRID:AB_2726071

This monoclonal targets Biotin

View all literature mentions

Biotin anti-human TNF-alpha (antibody)

RRID:AB_315256

This monoclonal targets TNF-alpha

View all literature mentions

Biotin anti-human IL-10 (antibody)

RRID:AB_315178

This monoclonal targets IL-10

View all literature mentions

IFN-g (antibody)

RRID:AB_395472

This monoclonal targets IFN-γ

View all literature mentions

Purified anti-human CD45 Recombinant (antibody)

RRID:AB_2749886

This recombinant monoclonal targets CD45

View all literature mentions